Skip to main content
SpringerLink
Log in

The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

The glutathione redox system, haemoglobin (Hb) oxidation, the activity of antioxidant enzymes and the lipid peroxidation product malonyl dialdehyde (MDA) were studied in red blood cells (RBCs) during administration of recombinant human erythropoietin (rhEPO) over 12 weeks in ten children maintained on haemodialysis. A rapid increase in the reticulocyte count was accompanied by a slower rise in total Hb concentration. The mean level of oxidized glutathione (GSSG) increased from 13.2±5.3 nmol/g Hb to 56.7±15.8 nmol/g Hb 4 weeks after the start of rhEPO (P<0.001), followed by a fall to the basal value. Reduced glutathione (GSH) levels showed a smaller though constant elevation during rhEPO therapy (P<0.001). Before rhEPO treatment, incubation of RBCs for 1 h with acetylphenylhydrazine induced a decrease in GSH concentration compared with controls (P<0.001), which became more pronounced in the first few weeks of rhEPO therapy (P<0.001). In addition, the percentage of Hb derivatives (metHb and haemichrome) increased in the first 4 weeks of rhEPO therapy (P<0.001). Although there was no significant difference between the values obtained preEPO and during EPO treatment, MDA levels were continuously higher and superoxide dismutase, catalase and glutathione peroxidase concentrations were lower than in the controls (P<0.001). These results are compatible with oxidative damage to the RBCs in the early period of rhEPO therapy in children with end-stage renal failure. The GSH-GSSG system, as an important cellular defence mechanism of the RBCs, appears to be severely affected.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Giardini O, Taccone-Gallucci M, Lubrano R, Ricciardi-Tenore G, Bandino D, Silvi I, Ruberto U, Casciani CU (1984) Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients. Nephron 36: 235–237

    Google Scholar 

  2. Taccone-Gallucci M, Lubrano R, Belli A, Meloni C, Morosetti M, Maschini L, Elhi M, Boffo V, Pisani F, Giardini O, Casciani U (1989) Disappearance of oxidative damage to red blood cell membranes in uraemic patients following renal transplant. ASAIO Trans 35: 533–535

    Google Scholar 

  3. Túri S, Németh I, Vargha I, Matkovics B, Dobos É (1991) Erythrocyte defence mechanisms against free oxygen radicals in haemodialysed uraemic children. Pediatr Nephrol 5: 179–183

    Google Scholar 

  4. Hörl WH, Riegel W, Steinhauer GH, Wanner C, Thaiss F, Bozkurt F, Haag M, Schollmeyer P (1986) Granulocyte activation during hemodialysis. Clin Nephrol 26: 530–534

    Google Scholar 

  5. El-Rashidy FH, Al-Turk WA, Stohs SJ (1984) Glutathione, glutathione reductase and glutathione S-transferase activities in erythrocytes and lymphocytes in chronic renal disease. Res Commun Chem Pathol Pharmacol 44: 423–430

    Google Scholar 

  6. Seth RK, Saini AS, Aggarwal SK (1985) Glutathione peroxidase activity and reduced glutathione content in crythrocytes of patients with chronic renal failure. Scand J Haematol 35: 201–204

    Google Scholar 

  7. Kishore BK, Gejyo F, Arakawa M (1983) Lipid peroxidation uraemia: malondialdehyde — a putative uraemic toxin. IRCS Med Sci 11: 750–751

    Google Scholar 

  8. Pfafferott C, Neiselman J, Hochstein P (1982) The effect of malonyl dialdehyde on erythrocyte deformability. Blood 59: 12–15

    Google Scholar 

  9. Stocks J, Kemp M, Dormandy T (1971) Increased susceptibility of red blood cell lipids to autooxidation in haemolytic states. Lancet I: 251–266

    Google Scholar 

  10. Esbach JW (1989) The anaemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 35: 134–148

    Google Scholar 

  11. Walluer SF, Kurnick J, Vautrin R, Ward HP (1977) The effect of the serum of uraemic patients on erythropoietin. Am J Hematol 3: 45–49

    Google Scholar 

  12. Moriyanna Y, Rege AB, Fisher JW (1975) Studies on an inhibitor of erythropoiesis. II. Inhibitor effects of serum from uremic rabbits on heme synthesis in rabbit bone marrow cultures. Proc Soc Exp Biol Med 148: 94–97

    Google Scholar 

  13. Tietze F (1969) Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: application to mammalian blood and other tissues. Anal Biochem 27: 502–522

    Google Scholar 

  14. Akerboom TPM, Sies H (1981) Assay of glutathione, glutathione disulphide and glutathione mixed disulphides in biological samples. Methods Enzymol 77: 373–382

    Google Scholar 

  15. Güntherberg H, Rapaport S (1968) Eine Methode zur Bestimmung des oxydierten Glutathions. Acta Biol Med Ger 20: 559–564

    Google Scholar 

  16. Beutler E (1957) The glutathione instability of drug-sensitive red cells. A new method for the in vitro detection of drug sensitivity. J Lab Clin Med 49: 84–95

    Google Scholar 

  17. Matkovics B, Novák Z, Hoang Duc Hahn, Szabó L, Vargha SzI, Zalesna G (1987) A comparative study on some important experimental animal peroxide metabolism enzymes. Comp Biochem Physiol [B] 56: 31–34

    Google Scholar 

  18. Misra HP, Fridovich I (1972) The role of superoxide anion in the antioxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 247: 3170–3175

    Google Scholar 

  19. Sedlak I, Lindsay RH (1968) Estimation of total protein-bound and nonprotein sulphydryl group in tissue with Ellman's reagent. Anal Biochem 25: 192–205

    Google Scholar 

  20. Chin DTY, Stults FH, Tappal AL (1976) Purification and properties of rat lung soluble glutathione peroxidase. Biochim Biophys Acta 445: 558–566

    Google Scholar 

  21. Placer ZA, Cusman L, Johnson BC (1966) Estimation of product of lipid peroxidation by malonyl dialdehyde in biochemical systems. Anal Biochem 16: 359–364

    Google Scholar 

  22. Lowry OH, Rosebrough NI, Farr AL, Randal RI (1951) Protein measurement with the folin phenol reagents. J Biol Chem 193: 265–275

    Google Scholar 

  23. Akhrem AA, Andreyuk GM, Kisel MA, Kiselev PA (1989) Hemoglobin conversion to hemichrome under the influence of fatty acids. Biochim Biophys Acta 992: 191–194

    Google Scholar 

  24. Szebeni J, Winterbourn CC, Carrell RW (1984) Oxidative interactions between haemoglobin and membrane lipid. A liposome model. Biochem J 220: 685–692

    Google Scholar 

  25. Sobota JT (1989) Recombinant human erythropoietin in patients with anaemia due to end-stage renal disease. US multicenter trials. Contrib Nephrol 76: 166–178

    Google Scholar 

  26. Scigalla P, Bonzel KE, Bulla M, Burghard R, Dippel J, Geisert J, Leumann E, Lilien TV, Müller-Wiefel DE, Offner G, Pistor K, Zoellner K (1989) Therapy of renal anaemia with recombinant human erythropoietin in children with end-stage renal disease. Contrib Nephrol 76: 227–240

    Google Scholar 

  27. Susuki M, Hirasawa Y, Hirashima K, Arakawa M, Odaka M, Ogura Y, Yoshivama Y, Sanaka T, Shinoda A, Morii H (1989) Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Contrib Nephrol 76: 179–192

    Google Scholar 

  28. Offner G, Hoyer PF, Latta Winkler L, Brodehl J, Scigalla P (1990) One year's experience with recombinant erythropoietin in children undergoing continuous ambulatory or cycling peritoneal dialysis. Pediatr Nephrol 4: 512–514

    Google Scholar 

  29. Esbach JW, Egrie JC, Downing RM, Browne JK, Adamson JW (1987) Correction of the anaemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316: 73–77

    Google Scholar 

  30. Nielsen OJ, Thaysen JH (1989) Response to erythropoietin in anaemic haemodialysis patients. J Intern Med 226: 89–94

    Google Scholar 

  31. Sinai-Trieman L, Salusky IB, Fine RN (1989) Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis. J Pediatr 114: 550–554

    Google Scholar 

  32. Schaefer RM, Kürner B, Zech M, Krahn R, Heidland A (1988) Therapie der renalen Anämie mit rekombinanten humanen Erythropoietin. Dtsch Med Wochenschr 113: 125–129

    Google Scholar 

  33. Bommer J, Alexion C, Müller-Bühl J (1988) Recombinant human erythropoietin therapy in haemodialysis patients. Dose determination and clinical experience. Nephrol Dial Transplant 2: 238–242

    Google Scholar 

  34. Srivastava SK, Beutler E (1969) The transport of oxidized glutathione from human erythrocytes. J Biol Chem 10: 9–16

    Google Scholar 

  35. Costagliola C, Romano L, Sorice P, Di Benedetto A (1989) Anaemia and chronic renal failure: the possible role of the oxidative state of glutathione. Nephron 52: 11–14

    Google Scholar 

  36. McCord J, Fridovich I (1969) Superoxide dismutase. An enzyme function for erythropoietin. J Biol Chem 244: 6049–6055

    Google Scholar 

  37. Eaton JW, Boraas M, Etkin NL (1972) Catalase activity and red cell metabolism. In: Brewer GJ (ed) Proceedings of the Second International Conference on Red Cell Metabolism and Function. Plenum, New York, pp 121–131

    Google Scholar 

  38. Vanella A, Geremia E, Tiriolo P, Giglio A, Tiriolo C, Vanella G, Ruggieri G (1981) Scavenger effect of alpha-mercatoproprionglycine on superoxide anion. IRCS Med Sci Biochem 9: 1124–1125

    Google Scholar 

  39. Janero DR (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 9: 515–540

    Google Scholar 

  40. Anderson KE, Goeger DE, Carson RW, Lee S-M K, Stead RB (1990) Erythropoietin for the treatment of porphyria cutanea tarda in a patient on longterm hemodialysis. N Engl J Med 322: 315–317

    Google Scholar 

  41. Kawabata T, Ogino T, Awai M (1988) Protective effects of glutathione against lipid peroxidation in chronically iron-loaded mice. Biochim Biophys Acta 1004: 89–84

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, Albert Szent-Györgyi Medical University, 14 Korányi u., H-6725, Szeged, Hungary

    Sándor Túri, Ilona Németh & Tibor Bodrogi

  2. Department of Biology, Attila József University, H-6725, Szeged, Hungary

    Ilona Varga & Béla Matkovics

Authors
  1. Sándor Túri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ilona Németh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ilona Varga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tibor Bodrogi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Béla Matkovics
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Túri, S., Németh, I., Varga, I. et al. The effect of erythropoietin on the cellular defence mechanism of red blood cells in children with chronic renal failure. Pediatr Nephrol 6, 536–541 (1992). https://doi.org/10.1007/BF00866497

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00866497

Key words

Search

Navigation